Revista Emprendedores has selected Topazium as one of the 50 most innovative Spanish start-ups of 2023

Revista Emprendedores have searched for the most innovative projects of 2023 in the Spanish market to produce the 8th Emprendedores List of innovative startups. Spanish, innovative and very young. We have passed through these three filters to the country’s leading companies to draw up what is already the 8th Entrepreneurs List of innovative startups. So…

Nutraceutical & functional food research & development webinar

NutriGuard is a machine learning framework designed and developed by Topazium to harness the potential of food components for promoting and preserving health. It is inspired by the need to understand the physiological effects exerted by food components from a well-grounded rationale based on scientific evidence. NutriGuard utilizes different sources of information to achieve its goal and…

Prospective evaluation of SkinGuard, a deep algorithmic framework for the classification of neoplastic skin lesions

Introduction. Diagnostic errors between nevic lesions and skin tumors are frequent for non-specialist physicians. Therefore, there is a need to create a simple and practical tool based on artificial intelligence to assists them in distinguishing potentially malignant lesions from benign ones, improving early detection of skin cancer. Objective. To evaluate the performance of SkinGuard, an…

El arte de la medicina hipocrática y la IA: un binomio al servicio del paciente

En un mundo en constante cambio y evolución como el nuestro, pocos métodos o doctrinas pueden tener el honor de permanecer vigentes durante más de 2.000 años. Uno de estos excepcionales casos es el método hipocrático, gracias al cual la medicina abandonó la superstición y la magia ejercidas por sacerdotes-médicos en aquella época y se…

Analysis of transcriptomic responses to SARS-CoV-2 reveals plausible defective pathways responsible for increased susceptibility to infection and complications and helps to develop fast-track repositioning of drugs against COVID-19

Background: To understand the transcriptomic response to SARS-CoV-2 infection, is of the utmost importance to design diagnostic tools predicting the severity of the infection. Methods: We have performed a deep sampling analysis of the viral transcriptomic data oriented towards drug repositioning. Using different samplers, the basic principle of this methodology the biological invariance, which means…

Detecting panitumumab/FOLFOX responders in K-Ras wild-type metastatic colorectal cancer through an artificial intelligence-based analytical tool

Background: Patients with K-RAS wild-type (WT) metastatic colorectal cancer (mCRC) are currently considered the optimal candidates for upfront treatment with combinations of chemotherapy and EGFR inhibitors. These combinations significantly extend overall survival (OS) compared to chemotherapy alone. However, a proportion of patients would not achieve this goal. This study has investigated the ability of an…

Use of deep learning frameworks to detect super-responder and super-survivor stage IV squamous non-small-cell lung cancer (NSCLC) patients treated with a gemcitabine and cisplatin combination

Background: Synthetic fingerprints integrate clinical data within computational models allowing the identification of particular clinical subpopulations at a given moment. We here describe a deep learning strategy to detect super-responder and super-survivor patients with squamous NSCLC by setting up synthetic fingerprints and using unsupervised deep learning frameworks (UDLF). Methods: Through www.projectdatasphere.org, we accessed the control…

Predicting disease progression and mortality in metastatic colorectal cancer patients (mCRC) through an artificial intelligence-based analytical tool

Background: Predicting the clinical course of metastatic disease remains a key challenge in CRC. Estimating prognosis of these late-stage patients can avoid undertreatment or overtreatment and also guide the follow-up intensity. This study has investigated the ability of an artificial intelligence-based analytical tool to identify those mCRC patients with high risk of disease progression and…